Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Karsten Geletneky"'
Autor:
Pauline Latzer, Henning Zelba, Florian Battke, Annekathrin Reinhardt, Borong Shao, Oliver Bartsch, Armin Rabsteyn, Johannes Harter, Martin Schulze, Thomas Okech, Alexander Golf, Christina Kyzirakos-Feger, Simone Kayser, Natalia Pieper, Magdalena Feldhahn, Julian Wünsche, Christian Seitz, Dirk Hadaschik, Claus Garbe, Till-Karsten Hauser, Christian la Fougère, Dirk Biskup, Dawn Brooke, David Parker, Uwe M. Martens, Gerald Illerhaus, Deborah T. Blumenthal, Ryan Merrell, Luisa Sánchez Lorenzo, Máté Hidvégi, Paula de Robles, Sied Kebir, William W. Li, Vincent W. Li, Matthew Williams, Alexandra M. Miller, Santosh Kesari, Michael Castro, Annick Desjardins, David M. Ashley, Henry S. Friedman, Patrick Y. Wen, Elisabeth C. Neil, Fabio M. Iwamoto, Bence Sipos, Karsten Geletneky, Lars Zender, Martin Glas, David A. Reardon, Saskia Biskup
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Current treatment outcome of patients with glioblastoma (GBM) remains poor. Following standard therapy, recurrence is universal with limited survival. Tumors from 173 GBM patients are analysed for somatic mutations to generate a personalized
Externí odkaz:
https://doaj.org/article/98a07e6f1b4647369483ebef527a8f94
Autor:
Dirk M. Nettelbeck, Mathias F. Leber, Jennifer Altomonte, Assia Angelova, Julia Beil, Susanne Berchtold, Maike Delic, Jürgen Eberle, Anja Ehrhardt, Christine E. Engeland, Henry Fechner, Karsten Geletneky, Katrin Goepfert, Per Sonne Holm, Stefan Kochanek, Florian Kreppel, Lea Krutzke, Florian Kühnel, Karl Sebastian Lang, Antonio Marchini, Markus Moehler, Michael D. Mühlebach, Ulrike Naumann, Roman Nawroth, Jürg Nüesch, Jean Rommelaere, Ulrich M. Lauer, Guy Ungerechts
Publikováno v:
Viruses, Vol 13, Iss 8, p 1420 (2021)
Virotherapy research involves the development, exploration, and application of oncolytic viruses that combine direct killing of cancer cells by viral infection, replication, and spread (oncolysis) with indirect killing by induction of anti-tumor immu
Externí odkaz:
https://doaj.org/article/2afbc836e8844aa9a40984a8fca1af73
Autor:
Jacek Hajda, Monika Lehmann, Ottheinz Krebs, Meinhard Kieser, Karsten Geletneky, Dirk Jäger, Michael Dahm, Bernard Huber, Tilman Schöning, Oliver Sedlaczek, Albrecht Stenzinger, Niels Halama, Volker Daniel, Barbara Leuchs, Assia Angelova, Jean Rommelaere, Christine E. Engeland, Christoph Springfeld, Guy Ungerechts
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Metastatic pancreatic cancer has a dismal prognosis, with a mean six-month progression-free survival of approximately 50% and a median survival of about 11 months. Despite intensive research, only slight improvements of clinical o
Externí odkaz:
https://doaj.org/article/18ddc49db19048d6bab8de3a50b57f70
Autor:
Ming-Han Tsai, Ana Raykova, Olaf Klinke, Katharina Bernhardt, Kathrin Gärtner, Carol S. Leung, Karsten Geletneky, Serkan Sertel, Christian Münz, Regina Feederle, Henri-Jacques Delecluse
Publikováno v:
Cell Reports, Vol 5, Iss 2, Pp 458-470 (2013)
The Epstein-Barr virus (EBV) is found in a variety of tumors whose incidence greatly varies around the world. A poorly explored hypothesis is that particular EBV strains account for this phenomenon. We report that M81, a virus isolated from a Chinese
Externí odkaz:
https://doaj.org/article/5097aae1ae254e12ae6e0065a45285ea
Publikováno v:
Viruses, Vol 9, Iss 12, p 382 (2017)
Glioblastoma, one of the most aggressive primary brain tumors, is characterized by highly immunosuppressive microenvironment. This contributes to glioblastoma resistance to standard treatment modalities and allows tumor growth and recurrence. Several
Externí odkaz:
https://doaj.org/article/5cbd05a97d744f68abe5289230081e50
Autor:
Franziska Greifzu, David Breuskin, Anna Prajsnar, Karsten Geletneky, Frank Bode, Jochen Tuettenberg, Joachim Oertel, Axel Stadie
ObjectiveDuraplasty with a dura mater substitute can become necessary after cranial or spinal surgery. Several dura grafts from different materials are available. The goal of this study was to assess the clinical performance of a suturable onlay dura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e72a18b68205652637c9176da01a976c
https://doi.org/10.1101/2022.09.08.22279716
https://doi.org/10.1101/2022.09.08.22279716
Autor:
Maike Delic, Roman Nawroth, Stefan Kochanek, Jürgen Eberle, Jean Rommelaere, Florian Kühnel, Julia Beil, Karl S. Lang, Mathias F. Leber, Antonio Marchini, Anja Ehrhardt, Karsten Geletneky, Susanne Berchtold, Katrin Goepfert, Jennifer Altomonte, Florian Kreppel, Guy Ungerechts, Henry Fechner, Dirk M. Nettelbeck, Per Sonne Holm, Ulrike Naumann, Assia L. Angelova, Jürg P. F. Nüesch, Michael D. Mühlebach, Markus Moehler, Christine E. Engeland, Ulrich M. Lauer, Lea Krutzke
Publikováno v:
Viruses, 13(8):1420
Viruses
Viruses, Vol 13, Iss 1420, p 1420 (2021)
Viruses
Viruses, Vol 13, Iss 1420, p 1420 (2021)
Virotherapy research involves the development, exploration, and application of oncolytic viruses that combine direct killing of cancer cells by viral infection, replication, and spread (oncolysis) with indirect killing by induction of anti-tumor immu
Autor:
Bernard Huber, Andreas Unterberg, Volker Daniel, Jeremy Fry, Rauf Bhat, Jan Oliver Neumann, Elena Terletskaia-Ladwig, Birgit Beelte, Jean Rommelaere, Jacek Hajda, Karin Jochims, Alexandra Just, Irina Kiprianova, Assia L. Angelova, Stephanie Löbhard, Karsten Geletneky, Barbara Leuchs, Johannes Hüsing, Andreas von Deimling, Tilman Schöning, Wolfgang Brück, David Capper, Veronika Frehtman, Andreas J. Bartsch, Ottheinz Krebs, Mandy Roscher, Michael Dahm
Publikováno v:
Molecular Therapy
Oncolytic virotherapy may be a means of improving the dismal prognosis of malignant brain tumors. The rat H-1 parvovirus (H-1PV) suppresses tumors in preclinical glioma models, through both direct oncolysis and stimulation of anticancer immune respon
Autor:
Oliver Sedlaczek, Bernard Huber, Jacek Hajda, Guy Ungerechts, Meinhard Kieser, Karsten Geletneky, Niels Halama, Jean Rommelaere, Volker Daniel, Albrecht Stenzinger, Dirk Jäger, Monika Lehmann, Assia L. Angelova, Michael Dahm, Barbara Leuchs, Christine E. Engeland, Christoph Springfeld, Tilman Schöning, Ottheinz Krebs
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-11 (2017)
BMC Cancer
BMC Cancer
Metastatic pancreatic cancer has a dismal prognosis, with a mean six-month progression-free survival of approximately 50% and a median survival of about 11 months. Despite intensive research, only slight improvements of clinical outcome could be achi
Autor:
Otto Kotterer, Lisa Mäder, Peter Huppert, Karsten Geletneky, Ajaz Ganai, Ilia Aroyo, Josef Schill, Regina Tröscher-Weber, Rainer Kollmar
Publikováno v:
Therapeutic hypothermia and temperature management. 9(3)
Targeted temperature management (TTM) might improve outcome of patients with severe subarachnoid hemorrhage (SAH) in which vasospasm, delayed cerebral ischemia (DCI), and increased intracranial pressure (ICP) are frequent and severe complications. A